<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We treated six patients with moderate to severe skin symptoms of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease with oral administration of <z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> (CsA) </plain></SENT>
<SENT sid="1" pm="."><plain>During the first two weeks, 5 mg/kg/day CsA twice a day was given and then the dose was reduced to 3 mg/kg/day </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0010783'>Erythema</z:hpo> nodosum like eruptions, oral <z:e sem="disease" ids="C0038363" disease_type="Disease or Syndrome" abbrv="">aphtha</z:e>, and <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> began to improve within three days, and four patients had complete remission by two weeks after the start of treatment </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient, a genital <z:mpath ids='MPATH_579'>ulcer</z:mpath> took almost three months to disappear </plain></SENT>
<SENT sid="4" pm="."><plain>In peripheral blood of patients treated with CsA 5 mg/kg/day for two weeks, there were decreases in the OKT4/OKT8 ratio </plain></SENT>
<SENT sid="5" pm="."><plain>After the reduction of the dosage, the ratio was temporarily increased, but it decreased to the <z:mpath ids='MPATH_458'>normal</z:mpath> range around the twelfth week of the treatment </plain></SENT>
<SENT sid="6" pm="."><plain>No clinically important side effects were seen </plain></SENT>
</text></document>